ENTRY       D02135            Mixture   Drug
NAME        Levodopa and benserazide hydrochloride;
            Madopar (TN)
COMPONENT   Levodopa [DR:D00059], Benserazide hydrochloride [DR:D01653]
CLASS       Neuropsychiatric agent
             DG01967  Antiparkinson agent
REMARK      Therapeutic category: 1169
            ATC code: N04BA02
            Product: D02135<JP>
EFFICACY    Antiparkinsonian
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BA Dopa and dopa derivatives
                 N04BA02 Levodopa and decarboxylase inhibitor
                  D02135  Levodopa and benserazide hydrochloride &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D02135  Levodopa and benserazide hydrochloride
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D02135  Levodopa and benserazide hydrochloride
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D02135  Levodopa and benserazide hydrochloride
DBLINKS     PubChem: 7849196
            LigandBox: D02135
///
